Knight Therapeutics Inc. KHTRF
OTC PK
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 30.40% | 73.38% | 530.54% | -17.18% | -4,517.98% |
| Total Depreciation and Amortization | -10.43% | 23.59% | 46.24% | 8.53% | 31.41% |
| Total Amortization of Deferred Charges | -- | -- | -- | 6.37% | -- |
| Total Other Non-Cash Items | 45.56% | 109.43% | 130.05% | 91.98% | 195.90% |
| Change in Net Operating Assets | 112.18% | -87.36% | 174.36% | 197.22% | -2.58% |
| Cash from Operations | 152.73% | 45.72% | 1,060.06% | 2,283.63% | 100.64% |
| Capital Expenditure | 23.18% | -0.13% | -832.90% | 9.45% | -8.57% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -100.00% | -- |
| Cash Acquisitions | -- | 92.10% | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 62.04% | -34.29% | -55.51% | -122.13% | -81.69% |
| Cash from Investing | 331.15% | 95.09% | -65.86% | -125.50% | -112.08% |
| Total Debt Issued | -- | -- | -- | 59.67% | -- |
| Total Debt Repaid | 47.43% | 31.30% | -362.89% | -274.70% | -65.02% |
| Issuance of Common Stock | 445.24% | 78.79% | -1.75% | -5.00% | -71.88% |
| Repurchase of Common Stock | -- | -17,200.00% | -146.25% | 41.73% | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 70.15% | 36.79% | -14.06% | -1.03% | -103.78% |
| Cash from Financing | 62.46% | -180.09% | -374.43% | -127.57% | -49.01% |
| Foreign Exchange rate Adjustments | -94.89% | 140.34% | 90.35% | -142.10% | 261.54% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 559.59% | 57.76% | 3.15% | -185.80% | -68.95% |